Similarly to BRAFV600E, the mutated RET protein kinases in MTC cells could regulate the expression of PD-L1 and the subsequent effectiveness of PD-1/PD-L1 blocking therapies, as suggested for melanoma and lung cancers 83, 84. The gene discussed is PDCD1; the disease is melanoma.